Debt-to-equity in % of Journey Medical Corp from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Journey Medical Corp quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
  • Journey Medical Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 282 %, a 27.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Journey Medical Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 282 -109 -27.8% 30 Sep 2025
Q2 2025 332 -10.6 -3.08% 30 Jun 2025
Q1 2025 361 -89.4 -19.8% 31 Mar 2025
Q4 2024 400 -182 -31.3% 31 Dec 2024
Q3 2024 391 -313 -44.5% 30 Sep 2024
Q2 2024 343 -305 -47.1% 30 Jun 2024
Q1 2024 451 +56.1 +14.2% 31 Mar 2024
Q4 2023 582 +307 +112% 31 Dec 2023
Q3 2023 704 +500 +245% 30 Sep 2023
Q2 2023 648 +353 +120% 30 Jun 2023
Q1 2023 395 31 Mar 2023
Q4 2022 275 31 Dec 2022
Q3 2022 204 30 Sep 2022
Q2 2022 295 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.